| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And President
1 company
Trenary C Russell III is a CEO And President at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $87K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2022 | OTLK Outlook Therapeutics, Inc. | CEO And President | Buy | 19,925 | $1.06 | $21,120.50 | +56.9% | +20.0% | +66.7% | |
| Dec 6, 2021 | OTLK Outlook Therapeutics, Inc. | CEO And President | Buy | 25,000 | $1.39 | $34,750.00 | +250.0% | +34.3% | -26.3% | |
| Dec 2, 2021 | OTLK Outlook Therapeutics, Inc. | CEO And President | Buy | 10,000 | $1.40 | $14,000.00 | New | +23.2% | -21.7% |